AbbVie 2013 Annual Report Download - page 95
Download and view the complete annual report
Please find page 95 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85 -
86 -
87 -
88 -
89 -
90 -
91 -
92 -
93 -
94 -
95 -
96 -
97 -
98 -
99 -
100 -
101 -
102 -
103 -
104 -
105 -
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
 |
 |
Accumulated Other Comprehensive Loss
The following table summarizes the changes in balances of each component of AOCI, net of tax for the
three year period ended December 31, 2013.
Unrealized
gains
Foreign Pension (losses) on Gains
currency and post- marketable (losses) on
translation employment equity hedging
(in millions) (brackets denote losses) adjustments benefits securities activities Total
Balance as of December 31, 2010 $ 303 $ (58) $ 9 $ 34 $ 288
Other comprehensive income before
reclassifications (295) (8) 17 (14) $(300)
Amounts reclassified from accumulated other
comprehensive income — 1 — (14) $ (13)
Net current-period other comprehensive income (295) (7) 17 (28) $(313)
Balance as of December 31, 2011 $ 8 $ (65) $ 26 $ 6 $ (25)
Other comprehensive income before
reclassifications 173 (157) (25) (9) $ (18)
Amounts reclassified from accumulated other
comprehensive income — 7 — (18) $ (11)
Net current-period other comprehensive income 173 (150) (25) (27) $ (29)
Separation-related adjustments — (296) — — $(296)
Balance as of December 31, 2012 $ 181 $(511) $ 1 $(21) $(350)
Other comprehensive income before
reclassifications 48 519 1 (77) $ 491
Amounts reclassified from accumulated other
comprehensive income — 79 — — $ 79
Net current-period other comprehensive income 48 598 1 (77) $ 570
Separation-related adjustments 241 (914) — 11 $(662)
Balance as of December 31, 2013 $ 470 $(827) $ 2 $(87) $(442)
The table below presents the significant amounts reclassified out of each component of accumulated
other comprehensive loss for the three year period ended December 31, 2013.
Years ended December 31 (in millions) 2013 2012 2011
Pension and post-employee benefits
Amortization of actuarial losses and other $114 $ 7 $ 2
Less tax expense (35) (—) (1)
Total reclassification, net of tax $ 79 $ 7 $ 1
Other
In addition to common stock, AbbVie’s authorized capital includes 200 million shares of preferred
stock, par value $0.01. As of December 31, 2013, no shares of preferred stock were issued or
outstanding.
91